Home>Topics>Companies>Eli Lilly

Eli Lilly LLY

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. UPDATE 3-Lilly profit beats estimates, helped by cost cuts

      Headlines

      Thu, 23 Apr 2015

      April 23 (Reuters) - Eli Lilly and Co soundly beat quarterly profit estimates on lower-than-expected spending on research and marketing, but revenue slipped as the stronger dollar hurt sales outside the United States.

    2. Lilly profit falls 27 percent, hurt by strong dollar

      Headlines

      Thu, 23 Apr 2015

      April 23 (Reuters) - Eli Lilly and Co reported a 27 percent fall in quarterly profit, hurt by a stronger dollar.

    3. Lower R&D Costs and Strong Pricing Power in the U.S. Buoy Lilly's 1Q: No Fair Value Change

      Commentary

      Thu, 23 Apr 2015

      Eli Lilly reported first-quarter results that ran ahead of our earnings expectations, as research and development costs and price increases

    4. Fitch Affirms Eli Lilly's IDR at 'A'; Outlook Stable

      Headlines

      Tue, 21 Apr 2015

      (The following statement was released by the rating agency) CHICAGO, April 21 (Fitch) Fitch Ratings affirms Eli Lilly & Co. Inc.'s (Lilly) long-term Issuer Default Rating (IDR) at 'A'. In addition, Fitch affirms the company

    5. UPDATE 1-Lilly's psoriatic arthritis drug succeeds in late-stage study

      Headlines

      Mon, 20 Apr 2015

      April 20 (Reuters) - Eli Lilly and Co said its experimental drug, ixekizumab, reduced the signs and symptoms of active psoriatic arthritis in patients more than a placebo did in a late-stage trial.

    6. Lilly's psoriatic arthritis drug succeeds in late-stage study

      Headlines

      Mon, 20 Apr 2015

      April 20 (Reuters) - Eli Lilly and Co said its experimental drug, ixekizumab, was more effective than a placebo in patients with active psoriatic arthritis, in a late-stage trial.

    7. New Indiana bill will contain language on sexual orientation

      Headlines

      Thu, 2 Apr 2015

      April 2 (Reuters) - A revision to Indiana's Religious Freedom Restoration Act will prohibit discrimination of people based on sexual orientation or gender identity, former Indianapolis Mayor and Eli Lilly executive Bart Peterson said at a news conference on Thursday.

    8. UPDATE 1-FDA recommends no changes to Lilly's schizophrenia injection use

      Headlines

      Mon, 23 Mar 2015

      March 23 (Reuters) - The U.S. Food and Drug Administration said it would not recommend changes to the prescribing or use of Eli Lilly and Co's schizophrenia drug after a review of two deaths.

    9. FDA recommends no changes to Lilly's schizophrenia injection use

      Headlines

      Mon, 23 Mar 2015

      March 23 (Reuters) - The U.S. Food and Drug Administration said it would not recommend changes to the prescribing or use of Eli Lilly and Co's schizophrenia drug after a review of two deaths.

    10. UPDATE 2-Pfizer, Lilly to resume study testing pain drug

      Headlines

      Mon, 23 Mar 2015

      March 23 (Reuters) - Pfizer Inc and Eli Lilly and Co will resume late-stage studies of their drug tanezumab for chronic pain after the U.S. Food and Drug Administration lifted a partial hold on trials of it and similar medicines.

    « Prev12345Next »
    Content Partners